Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients With End-Stage Renal Disease Receiving Chronic Hemodialysis
Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on c...
Saved in:
Published in | Circulation Journal Vol. 82; no. 2; pp. 586 - 595 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Japanese Circulation Society
25.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Conclusions:Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients. |
---|---|
AbstractList | The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.
Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm
. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.
Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients. The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.BACKGROUNDThe aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.METHODS AND RESULTSThree hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.CONCLUSIONSPatients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients. Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Conclusions:Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients. |
Author | Kakuta, Kentaro Tanoue, Akiko Fukui, Yoshihisa Senga, Michiharu Yamada, Tomomi Nomura, Shinsuke Isaka, Naoki Ito, Masaaki Matsuo, Hiroshi Sugimoto, Tadafumi Ogura, Toru Aoki, Toshikazu Ichikawa, Takehiko Takeuchi, Hideyuki Tanigawa, Takashi Dohi, Kaoru Nishimura, Yuki Yasutomi, Masashi Nishimura, Hiroyuki Mizutani, Yasuhide Machida, Hirofumi Ishikawa, Eiji Koyabu, Sukenari Sakurai, Masato Ohnishi, Takahiro Murata, Tomohiro Okamoto, Ryuji Nishikawa, Masakatsu Oosugi, Kazuki Kakimoto, Hitoshi |
Author_xml | – sequence: 1 fullname: Matsuo, Hiroshi organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 2 fullname: Dohi, Kaoru organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 3 fullname: Machida, Hirofumi organization: Department of Internal Medicine, Takeuchi Hospital – sequence: 4 fullname: Takeuchi, Hideyuki organization: Department of Internal Medicine, Takeuchi Hospital – sequence: 5 fullname: Aoki, Toshikazu organization: Department of Internal Medicine, Tohyama Hospital – sequence: 6 fullname: Nishimura, Hiroyuki organization: Department of Internal Medicine, Tohyama Hospital – sequence: 7 fullname: Yasutomi, Masashi organization: Department of Nephrology, Kuwana City Medical Center – sequence: 8 fullname: Senga, Michiharu organization: Department of Cardiology, Kuwana City Medical Center – sequence: 9 fullname: Ichikawa, Takehiko organization: Department of Cardiology, Kuwana City Medical Center – sequence: 10 fullname: Kakuta, Kentaro organization: Department of Cardiology, Yokkaichi Hazu Medical Center – sequence: 11 fullname: Mizutani, Yasuhide organization: Department of Nephrology, Yokkaichi Hazu Medical Center – sequence: 12 fullname: Tanoue, Akiko organization: Department of Internal Medicine, Murase Hospital – sequence: 13 fullname: Isaka, Naoki organization: Department of Internal Medicine, Murase Hospital – sequence: 14 fullname: Oosugi, Kazuki organization: Department of Internal Medicine, Owase General Hospital – sequence: 15 fullname: Koyabu, Sukenari organization: Department of Internal Medicine, Owase General Hospital – sequence: 16 fullname: Sakurai, Masato organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital – sequence: 17 fullname: Fukui, Yoshihisa organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital – sequence: 18 fullname: Kakimoto, Hitoshi organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital – sequence: 19 fullname: Sugimoto, Tadafumi organization: Department of Cardiology, Ise Red Cross Hospital – sequence: 20 fullname: Ohnishi, Takahiro organization: Department of Nephrology, Ise Red Cross Hospital – sequence: 21 fullname: Murata, Tomohiro organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 22 fullname: Ishikawa, Eiji organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 23 fullname: Okamoto, Ryuji organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 24 fullname: Yamada, Tomomi organization: Department of Translational Medical Science, Mie University Graduate School of Medicine – sequence: 25 fullname: Ogura, Toru organization: Clinical Research Support Center, Mie University Hospital – sequence: 26 fullname: Nishimura, Yuki organization: Clinical Research Support Center, Mie University Hospital – sequence: 27 fullname: Tanigawa, Takashi organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 28 fullname: Nomura, Shinsuke organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine – sequence: 29 fullname: Nishikawa, Masakatsu organization: Institute of Human Research Promotion and Drug Development, Mie University Faculty of Medicine – sequence: 30 fullname: Ito, Masaaki organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29093429$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtr3DAQgEVJaR7tvaeiYy9O9PLaOi7ubtMQSElSehRjWV5rsaWtJAfyS_p3a2c3CeTQi2YGfd8MzJyiI-edQegzJeeU5fxC26C359VVRouMcMnfoRPKRZGJkpGjp3yRyVLwY3Qa45YQJkkuP6DjKUoumDxBf1e68xpCY_0mwK6zGi9jNDEOxiXsW1zNf6DxXQqjTmOAHoNr8Hp0OlnvpnJZOx8G6G2yJmLr8E-YMpci_m1Th1euye4SbAy-NTP-zUYDca60sQ_WbXDVBe-mwZdm8NOs_jHa-BG9b6GP5tMhnqFf69V9dZld33z_US2vM50LmTKzIFA2RanrQtYFE7KhmhdtWwhOWqZrTRlt8oK1TCyAN3UNk8dJI6XgpdCSn6Gv-7674P-MJiY12KhN34MzfoyKylxyxiWhE_rlgI71YBq1C3aA8KielzkBZA_o4GMMpn1BKFHzvdTTvVR1pWih5ntNyuKNom2CebEpgO3_J6734jbOu32ZBCFZ3ZuDUDLF5udVfAU6CMo4_g9wBLek |
CitedBy_id | crossref_primary_10_2147_IJGM_S359168 crossref_primary_10_1053_j_ackd_2019_10_004 crossref_primary_10_1590_2175_8239_jbn_2021_s104 crossref_primary_10_1016_j_ijcha_2024_101505 crossref_primary_10_3389_fphys_2019_00144 crossref_primary_10_1007_s00380_021_01919_7 crossref_primary_10_1080_0886022X_2021_1885444 crossref_primary_10_1007_s00392_023_02153_z crossref_primary_10_1253_circj_CJ_19_1036 crossref_primary_10_1111_echo_15728 crossref_primary_10_1111_echo_14413 crossref_primary_10_1016_j_ahj_2022_02_001 crossref_primary_10_4103_heartviews_heartviews_37_23 crossref_primary_10_1016_j_cjca_2019_05_028 crossref_primary_10_1002_clc_23815 crossref_primary_10_1177_0896860820941371 crossref_primary_10_1136_heartjnl_2021_319604 crossref_primary_10_1038_s41598_020_73038_8 crossref_primary_10_14814_phy2_70050 crossref_primary_10_1186_s41100_021_00367_3 crossref_primary_10_1161_CIR_0000000000000979 crossref_primary_10_1016_j_ijcard_2022_01_043 crossref_primary_10_1007_s12574_020_00461_1 crossref_primary_10_1007_s12574_019_00436_x crossref_primary_10_1007_s10741_023_10376_5 crossref_primary_10_3390_biom13050773 crossref_primary_10_3390_cells10071824 crossref_primary_10_1007_s12410_020_9534_0 crossref_primary_10_3389_fneph_2023_1198560 crossref_primary_10_1093_ehjci_jead020 |
ContentType | Journal Article |
Copyright | 2018 THE JAPANESE CIRCULATION SOCIETY |
Copyright_xml | – notice: 2018 THE JAPANESE CIRCULATION SOCIETY |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1253/circj.CJ-17-0393 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1347-4820 |
EndPage | 595 |
ExternalDocumentID | 29093429 10_1253_circj_CJ_17_0393 article_circj_82_2_82_CJ_17_0393_article_char_en |
Genre | Multicenter Study Journal Article |
GroupedDBID | --- .55 29B 2WC 53G 5GY 5RE 6J9 AAUGY ACGFO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GX1 JSF JSH KQ8 M~E OK1 P2P RJT RNS RZJ TR2 W2D X7M XSB ZXP .GJ 3O- AAYXX CITATION OVT TKC CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c549t-e60a8d78cb79b7249d1c37ff7430f2cbc121d572f246a3dbbac5430d994384c93 |
ISSN | 1346-9843 1347-4820 |
IngestDate | Fri Jul 11 00:32:09 EDT 2025 Thu Apr 03 07:00:09 EDT 2025 Tue Jul 01 02:01:22 EDT 2025 Thu Apr 24 23:01:13 EDT 2025 Thu Aug 17 20:29:17 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | End-stage renal disease Echocardiography Aortic valve sclerosis Hemodialysis Left ventricle |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c549t-e60a8d78cb79b7249d1c37ff7430f2cbc121d572f246a3dbbac5430d994384c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/circj/82/2/82_CJ-17-0393/_article/-char/en |
PMID | 29093429 |
PQID | 1959323901 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1959323901 pubmed_primary_29093429 crossref_primary_10_1253_circj_CJ_17_0393 crossref_citationtrail_10_1253_circj_CJ_17_0393 jstage_primary_article_circj_82_2_82_CJ_17_0393_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-25 |
PublicationDateYYYYMMDD | 2018-01-25 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-25 day: 25 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Circulation Journal |
PublicationTitleAlternate | Circ J |
PublicationYear | 2018 |
Publisher | The Japanese Circulation Society |
Publisher_xml | – name: The Japanese Circulation Society |
References | 5. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, Betocchi S, et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 2010; 25: 1950–1954. 21. Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2968–2976. 22. Cowell SJ, Newby DE, Burton J, White A, Northridge DB, Boon NA, et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003; 58: 712–716. 23. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: A long-term retrospective study. Eur Heart J 1991; 12: 10–14. 10. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17: 1795–1801. 11. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005; 36: 2533–2537. 20. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037–2040. 26. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008; 29: 1043–1048. 6. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167–184. 13. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007; 115: 2856–2864. 4. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251–261. 14. Magne J, Mohty D, Boulogne C, Deltreuil M, Cassat C, Echahidi N, et al. Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction. Int J Cardiol 2015; 180: 158–164. 37. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K, et al. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging. Nephrol Dial Transplant 2011; 26: 1655–1661. 30. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59: 679–688. 1. Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant 1998; 13(Suppl 4): 44–48. 34. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005; 112: 1136–1144. 31. Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 50. 18. Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol 2013; 14: 280. 17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458. 32. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46: 291–298. 15. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421–2427. 2. Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69: 1535–1539. 8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14. 12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1–23; quiz 101–102. 16. Wang H, Liu J, Yao XD, Li J, Yang Y, Cao TS, et al. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry. Nephrol Dial Transplant 2012; 27: 4422–4429. 27. Iwata S, Hyodo E, Yanagi S, Hayashi Y, Nishiyama H, Kamimori K, et al. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol 2013; 163: 256–259. 35. Codolosa JN, Koshkelashvili N, Alnabelsi T, Goykhman I, Romero-Corral A, Pressman GS. Effect of mitral annular calcium on left ventricular diastolic parameters. Am J Cardiol 2016; 117: 847–852. 7. Masuda C, Dohi K, Sakurai Y, Bessho Y, Fukuda H, Fujii S, et al. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Cardiovasc Ultrasound 2011; 9: 31. 33. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136–141. 19. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875–877. 9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133. 25. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854–1863. 3. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013; 8: 2106–2116. 28. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Cleve Clin J Med 1989; 56: 590–596. 24. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617. 29. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005; 26: 1790–1796. 36. Dimitrow PP, Michałowska J, Sorysz D. The effect of hemodialysis on left ventricular outflow tract gradient. Echocardiography 2010; 27: 603–607. 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 35 14 36 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 31. Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 50. – reference: 7. Masuda C, Dohi K, Sakurai Y, Bessho Y, Fukuda H, Fujii S, et al. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Cardiovasc Ultrasound 2011; 9: 31. – reference: 2. Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69: 1535–1539. – reference: 24. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617. – reference: 33. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136–141. – reference: 9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133. – reference: 8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14. – reference: 18. Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol 2013; 14: 280. – reference: 25. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854–1863. – reference: 12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1–23; quiz 101–102. – reference: 30. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59: 679–688. – reference: 10. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17: 1795–1801. – reference: 17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458. – reference: 36. Dimitrow PP, Michałowska J, Sorysz D. The effect of hemodialysis on left ventricular outflow tract gradient. Echocardiography 2010; 27: 603–607. – reference: 27. Iwata S, Hyodo E, Yanagi S, Hayashi Y, Nishiyama H, Kamimori K, et al. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol 2013; 163: 256–259. – reference: 11. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005; 36: 2533–2537. – reference: 21. Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2968–2976. – reference: 34. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005; 112: 1136–1144. – reference: 23. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: A long-term retrospective study. Eur Heart J 1991; 12: 10–14. – reference: 13. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007; 115: 2856–2864. – reference: 14. Magne J, Mohty D, Boulogne C, Deltreuil M, Cassat C, Echahidi N, et al. Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction. Int J Cardiol 2015; 180: 158–164. – reference: 32. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46: 291–298. – reference: 1. Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant 1998; 13(Suppl 4): 44–48. – reference: 22. Cowell SJ, Newby DE, Burton J, White A, Northridge DB, Boon NA, et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003; 58: 712–716. – reference: 35. Codolosa JN, Koshkelashvili N, Alnabelsi T, Goykhman I, Romero-Corral A, Pressman GS. Effect of mitral annular calcium on left ventricular diastolic parameters. Am J Cardiol 2016; 117: 847–852. – reference: 20. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037–2040. – reference: 3. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013; 8: 2106–2116. – reference: 5. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, Betocchi S, et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 2010; 25: 1950–1954. – reference: 6. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167–184. – reference: 28. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Cleve Clin J Med 1989; 56: 590–596. – reference: 29. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005; 26: 1790–1796. – reference: 26. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008; 29: 1043–1048. – reference: 16. Wang H, Liu J, Yao XD, Li J, Yang Y, Cao TS, et al. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry. Nephrol Dial Transplant 2012; 27: 4422–4429. – reference: 4. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251–261. – reference: 19. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875–877. – reference: 15. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421–2427. – reference: 37. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K, et al. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging. Nephrol Dial Transplant 2011; 26: 1655–1661. – ident: 2 – ident: 18 – ident: 4 – ident: 12 – ident: 35 – ident: 33 – ident: 10 – ident: 16 – ident: 14 – ident: 31 – ident: 28 – ident: 24 – ident: 9 – ident: 7 – ident: 20 – ident: 26 – ident: 22 – ident: 17 – ident: 3 – ident: 5 – ident: 1 – ident: 36 – ident: 11 – ident: 19 – ident: 34 – ident: 13 – ident: 15 – ident: 32 – ident: 29 – ident: 30 – ident: 6 – ident: 8 – ident: 21 – ident: 27 – ident: 25 – ident: 23 |
SSID | ssj0029059 |
Score | 2.3863556 |
Snippet | Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD)... The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 586 |
SubjectTerms | Aged Aortic valve sclerosis Aortic Valve Stenosis Calcinosis Echocardiography Echocardiography - methods End-stage renal disease Heart Defects, Congenital - diagnostic imaging Hemodialysis Humans Kidney Failure, Chronic - complications Left ventricle Middle Aged Mitral Valve - pathology Parathyroid Hormone - blood Prospective Studies Renal Dialysis Risk Factors Ventricular Function, Left |
Title | Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients With End-Stage Renal Disease Receiving Chronic Hemodialysis |
URI | https://www.jstage.jst.go.jp/article/circj/82/2/82_CJ-17-0393/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/29093429 https://www.proquest.com/docview/1959323901 |
Volume | 82 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Circulation Journal, 2018/01/25, Vol.82(2), pp.586-595 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEDa7C0JcEK-F8pKRuKAqu4nzPqGq6qqqtIhDV-otip2EZh8JapMD_BH-LjO242R3KWK5RG1qO2nmi2c8nvmGkI88EqBIgswC3YELlIxZaZCHVub6RewXqRNxzB0-_RLMz7zFyl_t7d8bRC21DT8SP_-YV_I_UoVzIFfMkr2DZM2gcAI-g3zhCBKG4z_JeAZzl5ABpZJ3uhTjiSHaVIlXKH6BW8-tUAQb6Cc_AV2mXYATXqHReil5VdH38VXxrGJYbLMez6rMAnP0GxZ3qOQEKbdz0NjMS-mK0OS6oL6uasxBQYKTocE7LTdCVwgzLBW7qCvQBl6A8saimONhRx1a2nvPm20rXbzzEpT8ujTWeL1WwQlpvWkHvvZ1maVd86K9Mu2X6UWOxWDUb1n-o70oh24QByPwLJUyrWdu1wusOFKcT0d5dy60vIjZw-k-YgNYs8Hc7Xec3Oqbqv15S8MwWSZEwDM4P5ouLNDxmN3ca9MuguCGkjWhj7jogjESOUIyXSROmOAI--Q-g5WOzFdfmSglFtuy3p_5d3qnHUY4vnkP1yyrB-fbRrJG7Fo3Sftp-YQ81gsfOlEofkr28uoZeXiqQzuek1-3wEx7MNO6oBrMtAczBTDTHsz0GphpWdEOzBTBTA2YqQQz1WCmBsxUg5kOwfyCnJ3MltO5pauGWML34sbKAzuNsjASPIx5yLw4c4QbFgWYynbBBBcOczI_ZAXzgtTNOE-hn2tncey5kSdi95AcVHWVvyI0i2wOz9yOBRjahS-44wvfDRwwVgrB_XhEjrsnDvJUoTNY2eUy2SXlEflkenxXdDJ_aftZCdG01BONbhmxhOGh79E3WKcbmCBH5EMn_QS0Bm4Fwitct9sEKaVchv7OEXmpYGGuApiLXTBTX9_hXt-QR_1L-ZYcABLyd2CtN_y9xPNvVrn0TA |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Echocardiographic+Assessment+of+Cardiac+Structural+and+Functional+Abnormalities+in+Patients+With+End-Stage+Renal+Disease+Receiving+Chronic+Hemodialysis&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Matsuo%2C+Hiroshi&rft.au=Dohi%2C+Kaoru&rft.au=Machida%2C+Hirofumi&rft.au=Takeuchi%2C+Hideyuki&rft.date=2018-01-25&rft.issn=1346-9843&rft.eissn=1347-4820&rft.volume=82&rft.issue=2&rft.spage=586&rft.epage=595&rft_id=info:doi/10.1253%2Fcircj.CJ-17-0393&rft.externalDBID=n%2Fa&rft.externalDocID=10_1253_circj_CJ_17_0393 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon |